85
Views
25
CrossRef citations to date
0
Altmetric
Original Article: Inner Ear

Cochlear hair cell loss in single-dose versus continuous round window administration of gentamicin

, , , &
Pages 340-345 | Received 14 Jun 2004, Accepted 07 Oct 2004, Published online: 08 Jul 2009

References

  • Blakley BW. Clinical forum: a review of intratympanic therapy. Am J Otol 1997;18:520–6.
  • Wu IC, Minor LB. Long-term hearing outcome in patients receiving intratympanic gentamicin for Méniere's disease. Laryngoscope 2003;113:815–20.
  • Alzamil KS, Linthicum FH. Extraneous round window membranes and plugs: possible effect on intratympanic therapy. Ann Otol Rhinol Laryngol 2000;109:30–2.
  • Silverstein H, Todd Rowan P, Olds MJ, Rosenberg SI. Inner ear perfusion and role of round window patency. Am J Otol 1997;18:586–9.
  • Thomsen J, Charabi S, Tos M. Preliminary results of a new delivery system for gentamicin to the inner ear in patients with Meniere's disease. Eur Arch Otorhinolaryngol 2000; 257:362–5.
  • Hoffer ME, Kopke RD, Weisskopf P, Gottshall K, Allen K, Wester D, et al. Use of the round window microcatheter in the treatment of Menieres disease. Laryngoscope 2001;111: 2046–9.
  • Schoendorf J, Neugebauer P, Michel 0. Continuous intratympanic infusion via a microcatheter in Meni-ere's disease. Otolaryngol Head Neck Surg 2001;124: 203–7.
  • Lefebvre PP, Staecker H. Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of con-ventional therapy: a pilot study. Acta Otolaryngol 2002;122: 698–702.
  • Cayé-Thomasen P, Wagner N, Engmer C, Lauréll G, Bagger-Sjöbäck D, Thomsen J. An animal model for con-tinuous drug administration to the inner ear. Audiol Med 2004;2:174–8.
  • Johnson A-C, Canlon B. Progressive hair cell loss induced by toluene exposure. Hear Res 1994;75:201–8.
  • Oei ML, Segenhout HM, Dijk F, Stokroos I, van der Want JJ, Albers FW. Functional and anatomic alterations in the gentamicin-damaged vestibular system in the guinea pig. Otol Neurotol 2004;25:57–64.
  • Hoffer ME, Allen K, Kopke RD, Weisskopf P, Gottshall K, Wester D. Transtympanic versus sustained release adminis-tration of gentamicin: kinetics, morphology, and function. Laryngoscope 2001;111:1343–57.
  • Hibi T, Suzuki T, Nakashima T. Perilymphatic concentra-tion of gentamicin administered intratympanically in guinea pigs. Acta Otolaryngol 2001;121:336–41.
  • Plontke S, Wood AW, Salt AN. Analysis of gentamicin kinetics in fluids of the inner ear with round window administration. Otol Neurotol 2002;23:967–74.
  • Saijo S, Kimura RS. Distribution of HRP in the inner ear after injection into the middle ear cavity. Acta Otolaryngol (Stockh) 1984;97:593–610.
  • Salt AN, Ohyama K, Thalman R. Radial communi-cation between the perilymphatic scalae of the cochlea. II: Estimation by bolus injection of tracer into the sealed cochlea. Hear Res 1991;51:37–43.
  • Laurell G, Teixeira M, Sterkers 0, Bagger-Sjöbäck D, Eksborg S, Lidman 0, et al. Local administration of antioxidants to the inner ear. Hear Res 2002;173: 198–209.
  • Imamura S, Adams JC. Distribution of gentamicin in the guinea pig inner ear after local or systemic application. J Assoc Res Otolaryngol 2003;4:176–95.
  • Imamura S, Adams JC. Changes in cytochemistry of sensory and nonsensory cells in gentamicin-treated cochleas. J Assoc Res Otolaryngol 2003;4:196–218.
  • Salt AN, Kellner C, Hale S. Contamination of perilymph sampled from the basal cochlear turn with cerebrospinal fluid. Hear Res 2003;182:24–33.
  • Walsted A. Unpredictable hearing loss after intratympanic gentamicin treatment for vertigo. A new theory. Acta Otolaryngol 2001;121:42 —4.
  • Rask-Andersen H, Stahle J, Wilbrand H. Human cochlear aqueduct and its accessory canals. Ann Otol Rhinol Laryngol Suppl 1977;42:1–16.
  • Assimakopoulos D, Patrikakos G. Treatment of Meniere's disease by intratympanic gentamicin application. J Laryngol Otol 2003;117:10 — 6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.